Breakout Setups
DVA appears in our Breakout Setups screen. This means the stock shows strong technical strength, a constructive consolidation pattern, and enough volatility to support a potential breakout if price moves above resistance.
DAVITA INC (DVA) Stock Price & Overview
NYSE:DVA • US23918K1088
Current stock price
151.65 USD
-3.49 (-2.25%)
At close:
151.65 USD
0 (0%)
After Hours:
The current stock price of DVA is 151.65 USD. Today DVA is down by -2.25%. In the past month the price increased by 4.17%. In the past year, price increased by 7.45%.
DVA Key Statistics
52-Week Range101 - 159.42
Current DVA stock price positioned within its 52-week range.
1-Month Range143.07 - 156.15
Current DVA stock price positioned within its 1-month range.
- Market Cap
- 10.13B
- P/E
- 14.60
- Fwd P/E
- 10.74
- EPS (TTM)
- 10.39
- Dividend Yield
- N/A
DVA Stock Performance
Today
-2.25%
1 Week
-0.13%
1 Month
+4.17%
3 Months
+38.70%
Longer-term
6 Months +27.42%
1 Year +7.45%
2 Years +3.08%
3 Years +61.90%
5 Years +26.30%
10 Years +96.13%
DVA Stock Chart
DVA Stock Screens
DVA currently appears in the following ChartMill screener lists.
DVA Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to DVA. When comparing the yearly performance of all stocks, DVA is one of the better performing stocks in the market, outperforming 79.02% of all stocks.
Chartmill TA Rating
Chartmill Setup Rating
DVA Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to DVA. DVA has an excellent profitability rating, but there are concerns on its financial health.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
DVA Earnings
On February 2, 2026 DVA reported an EPS of 3.4 and a revenue of 3.62B. The company beat EPS expectations (6.68% surprise) and beat revenue expectations (2.49% surprise).
Next Earnings DateMay 5, 2026
Last Earnings DateFeb 2, 2026
PeriodQ4 / 2025
EPS Reported$3.40
Revenue Reported3.62B
EPS Surprise 6.68%
Revenue Surprise 2.49%
DVA Forecast & Estimates
14 analysts have analysed DVA and the average price target is 154.54 USD. This implies a price increase of 1.91% is expected in the next year compared to the current price of 151.65.
For the next year, analysts expect an EPS growth of 35.91% and a revenue growth 3.8% for DVA
Analysts
Analysts68.57
Price Target154.54 (1.91%)
EPS Next Y35.91%
Revenue Next Year3.8%
DVA Index Membership
DVA is currently included in the following stock indexes tracked on ChartMill.
DVA Financial Highlights
Over the last trailing twelve months DVA reported a non-GAAP Earnings per Share(EPS) of 10.39. The EPS increased by 9.37% compared to the year before.
Income Statements
Revenue(TTM)13.64B
Net Income(TTM)746.80M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.47% | ||
| ROA | 4.27% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
Chartmill High Growth Momentum
EPS Q2Q%51.79%
Sales Q2Q%9.87%
EPS 1Y (TTM)9.37%
Revenue 1Y (TTM)6.46%
DVA Ownership
Ownership
Inst Owners52.84%
Shares66.80M
Float33.10M
Ins Owners5.1%
Short Float %17.87%
Short Ratio7.47
DVA Industry Overview
DVA operates in the Health Care Services sub-industry within the Health Care sector. This group contains 50 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Strength Score
49/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
Industry Growth Score
87/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
52%
Outperformed 52% of sub-industries
3 Month Rank
62%
Outperformed 62% of sub-industries
6 Month Rank
48%
Outperformed 48% of sub-industries
Industry Fundamentals & Breadth
- Members
- 50
- New Highs
- 10%
- New Lows
- 6%
- Average ROE
- 10%
- Average Profit Margin
- 2.8%
- Average Operating Margin
- 5.2%
- Average P/E
- 41.9
- Average Fwd P/E
- 27.3
- Average Debt/Equity
- 0.8
DVA Competitors/Peers
The largest stocks on the US markets in the "Health Care Services" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.34 | 106.744B | ||
| CI | THE CIGNA GROUP | 8.22 | 76.614B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 109.63 | 30.529B | ||
| DGX | QUEST DIAGNOSTICS INC | 16.67 | 21.494B | ||
| LH | LABCORP HOLDINGS INC | 12.87 | 21.106B | ||
| GH | GUARDANT HEALTH INC | N/A | 11.422B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 33.1 | 9.266B | ||
| CHE | CHEMED CORP | 15.7 | 6.209B | ||
| HIMS | HIMS & HERS HEALTH INC | 47.14 | 6.193B | ||
| RDNT | RADNET INC | 86.89 | 4.389B | ||
| HNGE | HINGE HEALTH INC-A | 23.53 | 3.513B | ||
| BLLN | BILLIONTOONE INC CL A | 159.08 | 3.45B |
Related stock screener links
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About DVA
Company Profile
DaVita, Inc. engages in the provision of medical care services. The company is headquartered in Denver, Colorado and currently employs 78,000 full-time employees. The firm is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. The company also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
Company Info
IPO: 1995-10-31
DAVITA INC
2000 16th St
Denver COLORADO 80202 US
CEO: Javier J. Rodriguez
Employees: 78000
Phone: 13105362668
DAVITA INC / DVA FAQ
What does DAVITA INC do?
DaVita, Inc. engages in the provision of medical care services. The company is headquartered in Denver, Colorado and currently employs 78,000 full-time employees. The firm is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. The company also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
What is the current price of DVA stock?
The current stock price of DVA is 151.65 USD. The price decreased by -2.25% in the last trading session.
Does DVA stock pay dividends?
DVA does not pay a dividend.
What is the ChartMill rating of DAVITA INC stock?
DVA has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Is DAVITA INC (DVA) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on DVA.
What is the market capitalization of DVA stock?
DAVITA INC (DVA) has a market capitalization of 10.13B USD. This makes DVA a Large Cap stock.
Can you provide the short interest for DVA stock?
The outstanding short interest for DAVITA INC (DVA) is 17.87% of its float.